Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Basics of Compounding for Cough

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2004 - Endotoxin
View All Articles in Issue

Page(s):  462-465

Basics of Compounding for Cough Page 1
Basics of Compounding for Cough Page 2
Basics of Compounding for Cough Page 3
Basics of Compounding for Cough Page 4

Download in electronic PDF format for $75

Abstract:  Cough is a symptom of a number of pathologic conditions, including infections and pulmonary, cardiac, and gastrointestinal disorders. It also can be caused by medication. While numerous prescription and nonprescription treatments for cough are available, these are not suitable for all patients in all situations. Extemporaneous compounding allows preparation of customized formulations that contains a variety of difference components in a dosage form convenient for the patient. Formulas and methods are provided for several frequently prescribed compounds. The initial step in treating cough is eliminating exposure to any irritant or discontinuing any medication that might be causing the cough. Depending on the cause of the cough, drug therapies include antihistamines (with or without decongestant), intranasal or oral corticosteroids, antibiotics, bronchodilators, topical volatile agents (eg, camphor, menthol, thymol), guaifenesin (antitussive/expectorant), or centrally acting drugs that suppress the cough reflex (codeine sulfate, dextromorphan hydrobromide, hydrocodone bitartrate, hydromorphone hydrochloride).

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, continuing education, coughing, bronchial secretions, antitussive effects, central suppression, medication side effect, formulation: dextromorphan 30-mg capsules, formulation: terpin hydrate and codeine elixir, formulation: guaifenesin 100 mg/5 mL and promethazine hydrochloride 10 mg/5 mL cough syrup, formulation: dextromorphan hydrobromide 20-mg lollipops with menthol and eucalyptus oil, formulation: hydrocodone 5-mg or hydromorphone 1-mg troches, formulation: codeine sulfate 15-mg suppositories, formulation: dextromorphan 30-mg suppositories, formulation: inhalant volatiles for vaporizers

Related Categories: FORMULATIONS

Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Colds and Cough
Allen Loyd V Jr
Nov/Dec 2012
Pg. 480-483

Basics of Compounding for Terrorist Attacks, Part 2
Allen Loyd V Jr
Mar/Apr 2003
Pg. 129-134

View Sample
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Bogner Robin H
, Szwejkowski Jessica, Houston Alana
Sep/Oct 2001
Pg. 401-405

Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education
McElhiney Linda F
May/Jun 2009
Pg. 224-229

Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?
Williams LaVonn A
Mar/Apr 2010
Pg. 105-107

Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel
, Arnold John J, McKay Doug, Abill C Scott
May/Jun 2013
Pg. 247-253

Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal
, Karthik B, Venkatasan Suba
Nov/Dec 2022
Pg. 516-521

Benzonatate 100-mg Capsules
Allen Loyd V
Jul/Aug 2015
Pg. 326

Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
Sep/Oct 2017
Pg. 388-392

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Ploesser Jennifer
, Weinstock Leonard B, Thomas Erin
Mar/Apr 2010
Pg. 171-173

Pharmacogenomics: Precision Pharmacy in 503A Compounding
Drummond Joseph
, Bennet Daron, Allen Loyd V Jr
Mar/Apr 2018
Pg. 95-107

Dextromethorphan Hydrobromide 30-mg Troches
Allen Loyd V Jr
Jan/Feb 2009
Pg. 67

Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules
Allen Loyd V Jr
Nov/Dec 2015
Pg. 504

Basics of Compounding: Special Capsules
Allen Loyd V Jr
May/Jun 2016
Pg. 209-214

Basics of Compounding: Cosmetics for Special Populations and Using Cosmetics as Vehicles
Allen Loyd V Jr
Mar/Apr 2002
Pg. 102-105

The Basics of Compounding: Compounding Special Capsules
Allen Loyd V Jr
Jul/Aug 1999
Pg. 291-294

Return to Top